Evidence map›Paper›PMID 26773056›Full record

ArticleNucleic acids research2016

Alternative splicing creates two new architectures for human tyrosyl-tRNA synthetase.

Zhiyi Wei, Zhiwen Xu, Xiaotian Liu, Wing-Sze Lo, Fei Ye, Ching-Fun Lau, Feng Wang, Jie J Zhou, Leslie A Nangle, Xiang-Lei Yang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Inflammatory platelet production stimulated by tyrosyl-tRNA synthetase mimicking viral infection.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Zhiyi WeiIAS HKUST - Scripps R&D Laboratory, Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China Departmentof Biology, South University of Science and Technology of China, Shenzhen, Guangdong 518055, China.
Zhiwen XuIAS HKUST - Scripps R&D Laboratory, Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China Pangu Biopharma, Edinburgh Tower, The landmark, 15 Queen'sRoad Central, Hong Kong, China.
Xiaotian LiuDivision of Life Science, State Key Laboratory of Molecular Neuroscience Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.
Wing-Sze LoIAS HKUST - Scripps R&D Laboratory, Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China Pangu Biopharma, Edinburgh Tower, The landmark, 15 Queen'sRoad Central, Hong Kong, China.
Fei YeDivision of Life Science, State Key Laboratory of Molecular Neuroscience Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.
Ching-Fun LauIAS HKUST - Scripps R&D Laboratory, Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China Pangu Biopharma, Edinburgh Tower, The landmark, 15 Queen'sRoad Central, Hong Kong, China.
Feng WangIAS HKUST - Scripps R&D Laboratory, Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China Pangu Biopharma, Edinburgh Tower, The landmark, 15 Queen'sRoad Central, Hong Kong, China.
Jie J ZhouIAS HKUST - Scripps R&D Laboratory, Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China Pangu Biopharma, Edinburgh Tower, The landmark, 15 Queen'sRoad Central, Hong Kong, China.
Leslie A NangleaTyr Pharma, 3545 John Hopkins Court, Suite 250, San Diego, CA 92121, USA.
Xiang-Lei YangIAS HKUST - Scripps R&D Laboratory, Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China The Scripps Laboratories for tRNA Synthetase Research and the Departments of Chemical Physiology and of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Mingjie ZhangIAS HKUST - Scripps R&D Laboratory, Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China Division of Life Science, State Key Laboratory of Molecular Neuroscience Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.
Paul SchimmelIAS HKUST - Scripps R&D Laboratory, Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China The Scripps Laboratories for tRNA Synthetase Research and the Departments of Cell and Molecular Biology, and Chemistry, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA The Scripps Laboratories for tRNA Synthetase Research and Departments of Metabolism & Aging, The Scripps Research Institute, Jupiter, FL 33458, USA schimmel@scripps.edu.
University of Hong Kong · HKHong Kong University of Science and Technology · HKaTyr Pharma (United States) · US

Funding

Components of Translation in Signal TransductionR01CA092577 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI SCHIMMEL, PAUL R · 2001 to 2016
$4.5M
Elucidating pathological mechanism of DI-CMTCR01NS085092 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI YANG, XIANG-LEI · 2013 to 2017
$2.2M
NCI NIH HHS CA92577NCI NIH HHS R01 CA092577NINDS NIH HHS R01 NS085092
6 · The paper itself

Abstract

Many human tRNA synthetases evolved alternative functions outside of protein synthesis. These functions are associated with over 200 splice variants (SVs), most of which are catalytic nulls that engender new biology. While known to regulate non-translational activities, little is known about structures resulting from natural internal ablations of any protein. Here, we report analysis of two closely related, internally deleted, SVs of homodimeric human tyrosyl-tRNA synthetase (TyrRS). In spite of both variants ablating a portion of the catalytic core and dimer-interface contacts of native TyrRS, each folded into a distinct stable structure. Biochemical and nuclear magnetic resonance (NMR) analysis showed that the internal deletion of TyrRSΔE2-4 SV gave an alternative, neomorphic dimer interface 'orthogonal' to that of native TyrRS. In contrast, the internal C-terminal splice site of TyrRSΔE2-3 prevented either dimerization interface from forming, and yielded a predominantly monomeric protein. Unlike ubiquitous TyrRS, the neomorphs showed clear tissue preferences, which were distinct from each other. The results demonstrate a sophisticated structural plasticity of a human tRNA synthetase for architectural reorganizations that are preferentially elicited in specific tissues.

Indexed as

Alternative SplicingProtein MultimerizationProtein Structure, SecondaryAmino Acid SequenceAnimalsBase SequenceBlotting, WesternCatalytic DomainCell LineCell Line, TumorGene Expression ProfilingHumansIsoenzymesJurkat CellsMagnetic Resonance SpectroscopyMiceIsoenzymesTyrosine-tRNA Ligase

Identifiers

PMID26773056
PMCPMC4756856
OpenAlexW2238415257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.